Yeasts Provide Clues to Different Drug Responses

16 Apr 2014
Kerry Parker
CEO

Industry news

What are the genetic and environmental factors relating to drug reactions? How do these predict how a drug will affect us?

A major article in Science this week from researchers at the University of British Columbia exposed 6,000 strains of yeast to 3,000 drugs. Using yeast response data from the project, researchers found that the yeast cells reacted in 50 different main ways to the vast array of drugs.

Gene signatures predict drug response
These 50 major response types, known as gene signatures, are like fingerprints that identify all genes and their relevance to a specific drug treatment. Using genomics, proteomics and bioinformatics platforms, these networks were used to extrapolate the likely effects of related chemicals, their impact upon genetic pathways, and to identify putative gene functions.

Predictive medicine is a possible outcome of this discovery, given the relatively small number of gene signatures, using a person's genome to predict their drug response. The identification of better, more effective therapies for each of the gene signature could also be made easier.

Drug response reference map
"This is a starting reference map for understanding variation in drug response," says Guri Giaever, an associate professor in UBC's Faculty of Pharmaceutical Sciences, and a senior author on the study, published today in Science. "It won't be easy but our results suggest it is a solvable problem."
Corey Nislow, also associate professor in the faculty and senior author, says this research will help us better understand how and why some drugs work and others don't.

Of greatest interest is the relevance to cancer treatment. Researchers identified all genes that are essential for growth when cells are chemically stressed. Because cancer is principally a cell that grows out of control, the research points to different strategies to develop new drugs that target these genes.

Mapping the Cellular Response to Small Molecules Using Chemogenomic Fitness Signatures. Science, 2014; 344 (6180): 208.

Links

Tags

Genome AnalysisGenomics, the study of genomes, includes functional genomics, evolutionary genomics and comparative genomics. There are many genomic technologies such as DNA sequencing of whole genomes, computational biology and bioinformatics. DNA and nucleic acids must be isolated and concentrated from cells for analysis with kits, automated analyzers and software. Other useful technologies for studying genomics include PCR, microarrays and electrophoresis.ProteomicsProteomics is the systemic bioinformatics study of proteins and amino acids, including their structure, size, function and identification. Tools used in proteomics include chromatography, blotting and gels, protein arrays, mass spectrometry and ELISA and associated analysis software. Analyzers and proteomic systems should be sensitive, high resolution, fast and may be automated for high-throughput.Data AnalysisData analysis hardware and software is available to make data processing straight-forward yet powerful. Data software can be used for math and stats, technical graphing and image analysis. In addition, software is available for specific data analysis of electrophoresis, densitometry, ELISA and DNA sequencing.Medicinal ChemistryMedicinal chemistry is a broad discipline encompassing the design, identification, synthesis and development of chemicals in drug discovery. It includes a number of techniques covering structural biology, synthetic chemistry and molecular biology. Technologies used in medicinal chemistry include ADME, lab-on-a-chip, high content screening and assay assembly.Drug DevelopmentDrug development refers to the process of bringing a new drug to market.Cancer ResearchAlthough cancer is often referred to as a single condition, it actually consists of more than 100 different diseases. Microscopy, mass spectrometry, high throughput sequencing and flow cytometry are some of the most common techniques employed in cancer research labs.Drug MetabolismDrug metabolism is the enzymatic conversion within the body of pharmaceutical substances into other chemical compounds. The primary site for drug metabolism is the liver.